老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Bioxcel Therapeutics Inc.

1.07
+0.02001.90%
盤後：1.070.00000.00%19:56 EDT
成交量：118.94萬
成交額：123.67萬
市值：2,896.98萬
市盈率：-0.19
高：1.10
開：1.07
低：1.02
收：1.05
52周最高：8.08
52周最低：1.01
股本：2,707.46萬
流通股本：2,467.21萬
量比：1.12
換手率：4.82%
股息：- -
股息率：- -
每股收益(TTM):-5.7300
每股收益(LYR):-23.5105
淨資產收益率：-1766.94%
總資產收益率：-75.47%
市淨率：-0.30
市盈率(LYR):-0.05

資料載入中...

總覽公司新聞資訊公告
2020/05/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/12

重要事件披露

8-K - Current report
2020/04/15

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2020/03/09

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/09

重要事件披露

Current report, items 2.02 and 9.01
2020/03/06

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/24

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/21

重要事件披露

Current report, items 1.01 and 9.01
2020/02/19

重要事件披露

Current report, items 2.02 and 8.01
2020/02/18

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, item 7.01
2019/11/26

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/11/14

重要事件披露

Current report, items 2.02 and 9.01
2019/11/14

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/09/27

重要事件披露

Current report, items 8.01 and 9.01
2019/09/25

重要事件披露

Current report, item 1.02
2019/08/19

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/16

持股變動聲明

Statement of changes in beneficial ownership of securities
更多